Home ›
Trademark Categories ›
Pharmaceuticals ›
2000 ›
XE ›
XEPRILA
Trademark search for:
XEPRILA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2008-06-17 — Application filed
2008-06-20 — Application filed
2008-08-08 — Assigned to examiner
2008-08-12 — Final disposition recorded
2008-08-12 — Final disposition recorded
2008-08-12 — Final disposition recorded
2009-02-03 — Office action issued
2009-02-05 — Assigned to lie
2009-02-06 — Teas/email correspondence entered
2009-02-06 — Correspondence received in law office
2009-02-23 — Approved for pub - principal register
2009-02-24 — Law office publication review completed
2009-03-11 — Notice of publication
2009-03-31 — Published for opposition
2009-06-23 — Noa mailed - sou required from applicant
2009-12-23 — Sou teas extension received
2009-12-23 — Sou extension 1 filed
2010-01-22 — Teas delete 1(b) basis received
2010-02-12 — Case assigned to intent to use paralegal
2010-03-11 — 1(b) basis deleted; proceed to registration
2010-03-11 — Notice of allowance cancelled
2010-03-11 — Sou extension 1 granted
2010-04-20 — Registered-principal register
2010-12-23 — Teas change of correspondence received
2015-04-20 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2016-11-25 — Cancelled sec. 8 (6-yr)
2016-11-25 — Final status recorded
Owner Information
sanofi-aventis
Paris FR
sanofi-aventis
Paris FR
sanofi-aventis
Paris FR
Correspondent
G. Mathew Lombard Lombard & Geliebter LLP 1115 Broadway, 12th Floor New York, NY 10010 UNITED STATES
Filing Details
Filing Date:
2008-06-17
Status Date:
2016-11-25
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.